Who
Phillip M. Schneider
Director
Company insider
Files Form 4 as: Director, ARS Pharmaceuticals; Director, Longboard Pharmaceuticals; Director, Pfenex; Director, Arena Pharmaceuticals; Director, Auspex Pharmaceuticals; Director, Gen Probe; Director, Micromet.
In numbers
- Trades disclosed
- 98
- Buys
- 2
- Sells
- 2
- Bought
- $105K
- Sold
- $2.5M
- Companies
- 7
- Companies where not an officer
- 7
- First trade
- 31 Dec 2005
- Last trade
- 24 Jun 2026
- Last filed
- 26 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Jun 2026filed 26 Jun 2026 | SPRY ARS Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | SPRY ARS Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 25 Jun 2025filed 27 Jun 2025 | SPRY ARS Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 2 Dec 2024filed 2 Dec 2024 | Longboard Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —25,461 | filing |
| 2 Dec 2024filed 2 Dec 2024 | Longboard Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —12,367 | filing |
| 2 Dec 2024filed 2 Dec 2024 | Longboard Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —12,500 | filing |
| 2 Dec 2024filed 2 Dec 2024 | Longboard Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —22,500 | filing |
| 20 Jun 2024filed 24 Jun 2024 | SPRY ARS Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 23 May 2024filed 24 May 2024 | Longboard Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 27 Jun 2023filed 28 Jun 2023 | SPRY ARS Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 25 May 2023filed 26 May 2023 | Longboard Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 8 Nov 2022filed 10 Nov 2022 | SPRY ARS Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —153,647 | filing |
| 8 Nov 2022filed 10 Nov 2022 | SPRY ARS Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —76,823 | filing |
| 24 May 2022filed 31 May 2022 | Longboard Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —12,367 at $0.00 | filing |
| 1 Oct 2020filed 5 Oct 2020 | Pfenexoption or derivative | SEC FORM 4 Code U | —20,000 | filing |
| 1 Oct 2020filed 5 Oct 2020 | Pfenexoption or derivative | SEC FORM 4 Code U | —18,000 | filing |
| 1 Oct 2020filed 5 Oct 2020 | Pfenexoption or derivative | SEC FORM 4 Code U | —18,000 | filing |
| 1 Oct 2020filed 5 Oct 2020 | Pfenexoption or derivative | SEC FORM 4 Code U | —18,000 | filing |
| 1 Oct 2020filed 5 Oct 2020 | Pfenexoption or derivative | SEC FORM 4 Code U | —18,000 | filing |
| 1 Oct 2020filed 5 Oct 2020 | Pfenexoption or derivative | SEC FORM 4 Code U | —18,000 | filing |
News
No headline names them, or the companies they trade most, lately.